Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

April 14, 2015November 9, 2015

Aseptika Receives United States Patent For Respiratory Infection Test

COPD, News

Aseptika recently announced that it has been granted a United States patent protecting the company’s proprietary respiratory infection test — the Sputum test — which is designed to significantly benefit those ... Read more

April 14, 2015November 5, 2015

New CF Treatments Could Mean Sky-High Health Costs

Cystic Fibrosis, News

A recent research project by Prime Therapeutics LLC (Prime) found that new treatments targeting specific gene mutations that cause cystic fibrosis could drastically increase costs associated with treating the condition. These results were presented at the Academy of ... Read more

April 13, 2015April 13, 2015

Dennis Bookshester Joins LUNGevity Foundation Board Of Directors

News

LUNGevity Foundation, one of the largest organizations in the United States focused on lung cancer, recently announced that Dennis Bookshester is joining the Foundation’s Board of Directors. Bookshester is an accomplished businessman with proven experience and ... Read more

April 10, 2015November 5, 2015

Vantobra By PARI Pharma Received Marketing Authorization In Europe for Cystic Fibrosis

Cystic Fibrosis, News

Vantobra® by PARI Pharma is a novel, highly concentrated tobramycin nebulizer solution for inhalation delivered by a Tolero® nebuliser that received a Marketing Authorization granted by the European Commission in March. Vantobra offers ... Read more

April 9, 2015April 9, 2015

XBiotech Publishes Positive Results For Xilonix™ In Non-Small Cell Lung Cancer

Lung Cancer, News

The developer of True Human™ therapeutic antibodies, XBiotech Inc. recently announced the results of a clinical trial for non-small cell lung cancer (NSCLC) in which patients were treated with the Company’s lead True Human antibody, Xilonix™. The ... Read more

April 7, 2015November 5, 2015

Actavis Files ANDA for Generic Ambrisentan Tablets for PAH

News, Pulmonary Hypertension

Actavis recently confirmed that the company has filed an Abbreviated New Drug Application (ANDA) with the United States Food and Drug Administration (FDA) seeking approval to commercialize their formulation of Ambrisentan Tablets (5 and 10 mg). ... Read more

April 4, 2015November 5, 2015

iBio Arranges Production of IPF Therapy With Help From Caliber Biotherapeutics

Idiopathic Pulmonary Fibrosis, News

iBio, Inc. recently partnered with Caliber Biotherapeutics LLC to scale-up its production of materials for clinical advancement of IBIO-CFB03, the first of iBio’s proprietary anti-fibrosis products. Caliber’s production capabilities will be used for IND-enabling toxicology assessment ... Read more

April 2, 2015November 6, 2015

Ongoing Study Examines Asthma in Elderly

Asthma, News

Asthma is a chronic inflammatory disease often considered a childhood health condition but that can, in fact, affect older people. However, very little is known about what triggers asthma in senior individuals. Barbara ... Read more

April 1, 2015November 5, 2015

Pulmonary Hypertension Association Supporting Patients’ Access to Treatments Act

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) is fully supporting the Patients’ Access to Treatments Act (PATA), which was recently introduced in the House of Representatives by Lois Capps (D-CA) and David B. ... Read more

March 30, 2015November 9, 2015

AMC Health and Qualcomm Partner to Advance Care for COPD Patients

COPD, News

Qualcomm Life, Inc. and AMC Health recently announced a partnership to help accelerate improvements in the way population health management is carried out through enhancing connectivity and coordination of at-risk patients with diseases like COPD, asthma, heart failure, ... Read more